Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Neural Implants Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, the neural implants market size has seen a significant expansion. It is projected to increase from $5.39 billion in 2024 to $5.96 billion in 2025, with a compound annual growth rate (CAGR) of 10.6%. The historical growth can be linked to several factors, including the expansion of well-structured healthcare facilities, an increase in the elderly population, a preference for less invasive procedures, a rise in demand for individualized treatment options, and enhanced healthcare infrastructure.

How Much Will the Neural Implants Market Be Worth in 2029?

In the coming years, the market size for neural implants is projected to witness swift expansion, reaching a value of $8.8 billion in 2029 while growing at a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the forecast period can be linked to factors such as growing instances of neurological disorders, heightened patient awareness about innovative treatment options for such disorders, growing accessibility to efficient devices, increased preference for MR-conditional brain implants and the escalating application of high-frequency neuromodulation therapy. Within the forecast period, the market would be influenced by trends such as groundbreaking product innovations, technological evolution, progress in the field of neuroprosthetics, and the incorporation of deep learning algorithms in neural implants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15618&type=smp

Which is the Largest Company in the Neural Implants Market?

Major companies operating in the neural implants market are Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Smith & Nephew plc, Integra LifeSciences, Cochlear Ltd., LivaNova PLC, Renishaw plc, MicroPort Scientific Corporation, Nevro Corp., Inspire Medical Systems Inc., Cyberonics Inc., Axonics Modulation Technologies Inc., Saluda Medical, NeuroPace Inc., Fisher Wallace, BioControl Medical, Cerbomed GmbH, Nuvectra Corporation

What Are the Main Market Drivers in the Neural Implants Industry?

The escalating incidences of neurological conditions are anticipated to fuel the expansion of the neural implants market in the future. Neurological disorders, which involve the nervous system and comprise anatomical, biochemical, or electrical irregularities in the brain, spinal cord, or peripheral nerves, have been surging due to various factors like the aging population, genetic predispositions, and shifts in diagnostic standards. Neural implants are utilized to deal with and regulate diverse neurological diseases by directly interfacing with the nervous system, thereby recovering or augmenting neural functions. These implants offer a customized recourse, which may enhance therapeutic efficacy while curtailing harmful effects, especially in ailments like Parkinson’s disease, epilepsy, and spinal cord injuries. For example, in March 2022, as reported by the Alzheimer’s Association, a US-based voluntary health organization that centers on Alzheimer’s disease care, almost 7 million Americans aged 65 or older suffered from Alzheimer’s dementia, and this figure is anticipated to soar to 13.8 million by 2060. In addition, the healthcare and long-term care expenditure for individuals coping with dementia are expected to hit $360 billion in 2024 and nearly $1 trillion in 2050. Hence, the increasing prevalence of neurological disorders is contributing significantly to the growth of the neural implants market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15618&type=smp

How Is the Neural Implants Market Segments Structured?

The neural implants market covered in this report is segmented –

1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)

2) By Application: Chronic Pain, Parkinson’s Disease (PD), Epilepsy, Other Applications

3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers

Subsegments:

1) By F And B Spinal Cord Stimulation (Scs): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation

2) By Deep Brain Stimulation (Dbs): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs

3) By Vagus Nerve Stimulation (Vns): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators

What Strategic Trends Are Transforming the Neural Implants Market?

Key players in the neural implant market, such as deep brain stimulation (DBS) device manufacturers, are focusing on creating ground-breaking products to treat movement related disorders, like Parkinson’s disease and essential tremors, giving them a competitive advantage within the market. DBS devices are medical implants that work by sending electrical impulses to specific brain regions to treat neurological disorders. For example, Abbott Laboratories, a medical devices and health services company based in the US, in January 2024, introduced Liberta RC, a compact rechargeable DBS device that holds the record for being the smallest in the world with remote programming. This is purposed for those suffering from movement disorders and demands the least recharges of any FDA-approved DBS system, needing only about 10 recharging sessions each year for the majority of users. The Liberta RC is part of Abbott’s exclusive NeuroSphere virtual clinic, which offers customers the convenience of connecting with clinicians, verifying the correct settings and functionality, and receiving updated treatment settings remotely. The system uses a wireless charger which can be placed above the device, letting users stay active even while charging it. The device is designed to provide practical notifications and adjustable preferences, making the charging experience custom-tailored for each user.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report

Which Global Regions Offer the Highest Growth in the Neural Implants Market?

North America was the largest region in the neural implants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15618

This Report Delivers Insight On:

1. How big is the neural implants market, and how is it changing globally?

2. Who are the major companies in the neural implants market, and how are they performing?

3. What are the key opportunities and risks in the neural implants market right now?

4. Which products or customer segments are growing the most in the neural implants market?

5. What factors are helping or slowing down the growth of the neural implants market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model